All Infection Prevention & Control articles – Page 11
-
NewsCFA publishes timely new industry-led UK Ready to Eat Foods Safety and Shelf Life Guidance
New industry-led good practice guidance for manufacturers and retailers of certain ready to eat (RTE) foods will be published on 12 January 2026 to help Food Business Operators (FBOs), Competent Authorities (CAs) and enforcement officers manage the risk posed by Listeria monocytogenes in those products.
-
NewsCandida auris: genetic process revealed which could be treatment target for deadly fungal disease
Scientists have discovered a genetic process which could unlock new ways to treat a mysterious and deadly fungal infection which has shut down multiple hospital intensive care units.
-
NewsHigh-dose antibiotic does not reduce mortality in tuberculous meningitis
The first trial examining the effects of higher rifampicin doses on tuberculosis survival has been completed. The study found no evidence of a beneficial effect from high-dose rifampicin.
-
NewsFiltering the invisible: New evidence points to more efficient indoor air microbe sampling
Using fluorescence-based detection, a new study provides clear, quantitative evidence that sampling principle, collection medium, and airflow rate strongly shape how well indoor microbial aerosols can be measured.
-
NewsNew findings on Candida auris open up potential targets for future therapies
A study shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B.
-
NewsBeing infected or vaccinated first influences COVID-19 immunity
A new study analysing the immune response to COVID-19 sheds light on an important question: does it matter whether a person was first infected or first vaccinated? According to the results, the order of the events does alter the outcome.
-
NewsScientists identify potential therapy and diagnostic markers for cerebral malaria
Researchers examined whether methylene blue could mitigate brain injury during severe malaria, and whether a practical set of blood biomarkers could help clinicians identify cerebral malaria early and track how patients respond to treatment.
-
NewsCytomegalovirus breakthrough could lead to new treatments
Researchers have developed a new type of antibody with a modified structure that can outsmart cytomegalovirus and neutralize its ability to evade the immune system.
-
NewsReal-world data gives Africa a smarter path to fighting HIV and TB
African biostatisticians have offered a powerful, data-driven alternative that can accurately inform HIV policy, reduce healthcare costs, and save more lives.
-
NewsAn enzyme neutralizes pathogens by cleaving a bacterial toxin
Researchers have discovered an enzyme that neutralizes the virulence factor malleicyprol in the bacterium Burkholderia pseudomallei, considered one of the most dangerous bacterial pathogens in the tropics.
-
NewsYour genes may influence gut microbiome of others, rat study shows
New research, carried out by studying more than four thousand animals, reveals that the composition of the rat gut microbiome is shaped not only by an individual’s own genes but also by the genes of the individuals they share a living space with.
-
NewsSilent dengue infections may hold clues to future vaccine design, study finds
Researchers report the first single-cell immune atlas of asymptomatic dengue, offering a rare look at how the immune system can defeat the virus without triggering illness. The work could help guide the design of safer and more effective dengue vaccines.
-
NewsEvaluation of antiviral activity of organic–polyoxometalate hybrids based on berberine against encephalomyocarditis virus in vitro
A new study promotes the development of POM-based drugs for clinical application by controlling the organic cations on the surface of organic–POM hybrids, ultimately yielding new POM drugs with high efficiency and low toxicity.
-
News4 million euros for study with personalized phage therapy
UMC Utrecht has received a grant of 4 million euros for the first clinical study in the Netherlands involving a customized therapy with bacteriophages for patients with recurrent urinary tract infections.
-
CareersScientific Event Travel Grant: how the Safepork conference surpassed my expectations
Shan Goh from the University of Hertfordshire reports back on the International Symposium on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork held in Rennes, France, in October. Shan was supported with a Scientific Event Travel Grant awarded by AMI.
-
NewsNew one-two punch could knock out drug-resistant TB
Researchers found that pairing the antibiotic rifampicin with a second compound turned multidrug resistance into a weakness—providing proof of concept for using basic science to design life-saving dual-drug strategies.
-
NewsA new way to diagnose deadly lung infections and save lives
Researchers have found a way to identify lung infections in critically ill patients by pairing a generative AI analysis of medical records with a biomarker of lower respiratory infections.
-
NewsNew method accelerates resistance testing in urinary tract infections
Researchers have developed two methods that allow urine samples to be tested directly for antibiotic susceptibility. Because the procedures do not require standardized bacterial suspensions, the time to result is reduced by up to 24 hours compared to conventional testing.
-
CareersCBCTA 2024 oral presentation winners: Isabella and Lia take home the honours
Letters in Applied Microbiology sponsored the best oral presentation award at the 29th Brazilian Congress of Food Science and Technology (CBCTA 2024). Winner Isabella Bassoto Xavier and runner-up Lia Mariano Aquino take a dive into their research.
-
NewsStudy uncovers new drug target for huge class of viruses
A study reveals how enteroviruses—including pathogens that cause polio, encephalitis, myocarditis, and the common cold—initiate replication by hijacking host-cell machinery.